Latest news with #TribecaFestival
Pink Villa
2 hours ago
- Entertainment
- Pink Villa
Titan: The OceanGate Disaster OTT Release- When and Where to Watch, What to Expect and More
A year after the ill-fated Titan submersible mission ended in catastrophe, Netflix is bringing the story back into the spotlight with Titan: The OceanGate Disaster. Directed by Oscar-winning documentarian Mark Monroe, the film investigates the 2023 incident that left five people dead after their deep-sea expedition to the Titanic wreck site went fatally wrong. Titan: The OceanGate Disaster release date and where to watch Titan: The OceanGate Disaster will begin streaming globally on Netflix from Wednesday, June 11, 2025. This comes after its world premiere at the Tribeca Festival on June 6, 2025. The film has already drawn attention for its gripping trailer and serious tone, and pieces together never-before-seen footage, audio recordings, and internal documents to reconstruct one of the most disturbing deep-sea tragedies in modern history. Titan: The OceanGate Disaster plot and trailer In June 2023, five individuals boarded OceanGate's Titan submersible to visit the Titanic wreck site, paying USD 250,000 each for what they believed would be a historic journey. Less than two hours into the dive, the sub lost contact. Four days later, hopes were extinguished as the U.S. Navy confirmed an implosion had occurred. This documentary investigates how it all went wrong—and who knew it could. Titan: The OceanGate Disaster exposes the internal warnings that went ignored, including safety test omissions, design flaws, and the company's decision to use carbon fiber instead of standard titanium for the hull. Engineers' concerns were dismissed by OceanGate CEO Stockton Rush, whose vision of 'disruptive innovation' prioritized commercial fame over passenger safety. One expert likens the experience of boarding Titan to 'stepping inside a bomb made of Play-Doh.' The passengers—Rush, Hamish Harding, Shahzada Dawood and his son Suleman, and Titanic expert Paul-Henri Nargeolet—were casualties of this venture built on ignored warnings. Internal footage and interviews also reveal how those inside the company feared retaliation for speaking up. The Titan: The OceanGate Disaster documentary ultimately uncovers how a company that sold extreme adventure collapsed under its own reckless ambition. The OceanGate corporation ceased operations shortly after the incident and is now the subject of lawsuits and public scrutiny.
Forbes
2 hours ago
- Entertainment
- Forbes
Eddie Vedder Amplifies Fight Against Childrens Butterfly Disease
NEW YORK, NEW YORK - FEBRUARY 03: Eddie Vedder And The Earthlings perform at theBeacon Theatre on ... More February 03, 2022 in New York City. (Photo by) Pearl Jam's frontman turns his platform into a powerful force for epidermolysis bullosa research, just as breakthrough gene therapies offer unprecedented hope. Matter of Time, a documentary that follows Eddie and Jill Vedder and a passionate community uniting to cure a devastating disease, will have its world premiere to a sold-out audience at the 24th Tribeca Festival in New York on Thursday, June 12th. The film captures the electrifying energy of Vedder's solo concerts in Seattle, organized to raise funds for Epidermolysis Bullosa (EB) - a rare and debilitating genetic skin disorder that mostly affects children, causing fragile, blistering skin. When Pearl Jam's Eddie Vedder took the stage in Seattle in October 2023, he wasn't just performing for his devoted fanbase. The legendary musician was on a mission that extended far beyond entertainment—raising critical funds for epidermolysis bullosa (EB) research while documenting the journey in what would become the compelling documentary Matter of Time. All proceeds from these concerts went directly to EB Research Partnership (EBRP), the world's largest organization funding research for EB, with the ambitious goal of finding a cure by 2030. 'It's so special to be playing for a purpose, the purpose being this incredible mission,' Vedder told in a trailer for the upcoming film. His words capture a moment of convergence between celebrity advocacy and scientific breakthrough that couldn't be more timely. The Perfect Storm of Progress The Vedders' fundraising concerts come at a pivotal moment in the fight against EB, a devastating genetic condition that causes the skin to blister and tear at the slightest touch—earning it the heartbreaking nickname 'butterfly disease' because patients' skin is as fragile as a butterfly's wings. The timing is particularly significant given the recent wave of therapeutic breakthroughs that have transformed what was once considered an untreatable condition into one where hope is becoming reality. The disease affects approximately 1 in 50,000 births globally, with patients enduring a lifetime of painful wounds, restricted movement, and often shortened lifespans due to complications. For decades, treatment was limited to wound care and pain management. Today, that landscape is rapidly changing. Professor Jean Tang, Stanford Medicine Gene Therapy Breakthrough Reshapes Treatment Landscape The scientific community has achieved what many considered impossible just years ago. FDA approves Vyjuvek, a herpes-simplex virus type 1 vector-based gene therapy, for the treatment of wounds in patients 6 months of age and older with dystrophic epidermolysis bullosa—marking the first approved topical gene therapy for this devastating condition. This groundbreaking treatment represents more than just medical progress; it embodies the same spirit of hope that the Vedders channels in advocacy. A gene therapy gel applied to the wounds of nine people - three of whom were children - with the blistering skin disease epidermolysis bullosa helped the wounds heal and remain healed for several months in clinical trials led by Stanford Medicine researchers. The therapy works by delivering the correct genetic code directly to affected skin areas, essentially teaching the body to produce the missing proteins that would normally hold skin layers together. For patients who have lived with chronic, painful wounds for decades, this represents nothing short of a miracle. DNA and Gene Therapy The Power of Purpose-Driven Advocacy Jill and Eddie Vedder co-founded EBRP with a group of families, with the sheer intent of curing this devastating disease, working tirelessly to raise awareness and drive resources toward groundbreaking research. Produced by Door Knocker Media in association with EB Research Partnership and the Vitalogy Foundation, Matter of Time blends powerful music with the poignant, real-life stories of patients, families, researchers, and thought leaders, revealing how determination and innovation are paving the way toward a cure. The film shows a community fiercely dedicated to ending EB, capturing the spirit, resilience, and grit needed to tackle this challenging but achievable mission The Vedders' approach to advocacy demonstrates how celebrity platforms can accelerate medical research in meaningful ways. Rather than simply writing a check, the musician has created a multimedia experience that educates audiences while generating substantial funding. The documentary Matter of Time showcases both the human stories behind EB and the cutting-edge research offering new hope. 'The goal is treatments. The goal is ultimately a cure,' Vedder says. 'It brings a sense of hope that feels like just a matter of time.' This sentiment perfectly captures the current moment in EB research, where multiple therapeutic approaches are showing remarkable promise. The musician's concerts weren't just fundraising events—they were awareness campaigns that brought a rare disease into the mainstream conversation. This type of advocacy has proven crucial for rare disease research, where limited patient populations often mean limited research funding and pharmaceutical interest. Multiple Pathways to Healing The field of EB treatment is experiencing what researchers call a 'therapeutic renaissance.' Beyond the FDA-approved topical gene therapy, several other approaches are showing promise: The Economic Impact of Breakthrough Therapies The development of EB treatments represents a significant economic opportunity within the rare disease pharmaceutical market. Gene therapies, while expensive to develop and initially costly to patients and healthcare systems, often prove cost-effective over time by preventing the chronic care needs that characterize rare diseases. For EB patients, traditional care involves constant wound dressing changes, pain management, nutritional support, and management of complications—costs that can exceed hundreds of thousands of dollars annually per patient. Curative or highly effective treatments, while carrying high upfront costs, can dramatically reduce these ongoing expenses while immeasurably improving patient quality of life. Jill Vedder, chairwoman of EBRP, said, 'It's amazing to witness how far we've come. Epidermolysis Bullosa may be rare, but through the tireless work of our community, our message is reaching more people than ever. This is more than awareness; it's an urgent push to cure EB by 2030, and together, I know we can make it happen.' BEVERLY HILLS, CA - MARCH 04: Jill and Eddie Vedder Beverly Hills, California. (Photo by J. ...) Celebrity Advocacy's Growing Impact on Medical Research The Vedders' commitment to EB research reflects a broader trend of entertainment figures using their platforms for targeted medical advocacy. Unlike general health awareness campaigns, this focused approach allows celebrities to drive significant resources toward specific conditions that might otherwise struggle for attention. The musician's concerts and documentary represent what researchers call 'translational advocacy'—efforts that don't just raise awareness but directly fund the research needed to develop treatments. This model has proven particularly effective for rare diseases, where traditional pharmaceutical development models often fall short due to small patient populations. "We are thankful for the Vedders' commitment to this community, their platform has accelerated an innovative approach for medical research,' said Michael Hund, CEO of EB Research Partnership, 'Our hope is that our model for EB of novel technology solutions, inspiring collaboration across the medical community, and a pioneering venture philanthropy investment strategy, can lead to not only treatments and cures for EB, but also provide a road map for the greater rare disease population." Looking Toward a Future Without EB The convergence of scientific breakthrough and celebrity advocacy suggests that EB may soon join the ranks of genetic diseases that have been transformed from fatal to manageable or even curable. Recent breakthroughs in gene therapy continue to transform the landscape of therapies for epidermolysis bullosa (EB), offering encouraging outcomes for patients suffering from this severe blistering skin disease. For families affected by EB, the message from the Vedders' advocacy and recent scientific advances is clear: hope is not just possible—it's scientifically justified. The combination of approved therapies, promising clinical trials, and sustained advocacy efforts suggests that the 'matter of time' Vedder references may be shorter than many dared hope. The Road Ahead As Matter of Time prepares for release, it will likely serve as both documentation of current progress and catalyst for future advances. The film promises to showcase the human faces behind the science, making the urgent need for continued research impossible to ignore. The story of EB treatment development demonstrates how breakthrough medical advances often require more than just scientific innovation—they need sustained advocacy, patient courage, and public support. The Vedders' commitment to this cause exemplifies how celebrity platforms, when used thoughtfully, can accelerate the translation of laboratory discoveries into real-world treatments. For the EB community, this moment represents unprecedented convergence of hope and possibility. Between approved gene therapies, promising research pipelines, and sustained advocacy efforts, the future for butterfly children looks brighter than ever before. As Vedder suggests, it truly may be just a matter of time.
Time of India
6 hours ago
- Entertainment
- Time of India
'Call Her Daddy' podcaster Alex Cooper opens up about sexual harassment by a former soccer coach: "If I didn't follow this woman's rules..."
Alex Cooper , the 'Call Her Daddy' podcaster, recently opened up about getting sexually harassed by her soccer coach, Nancy Feldman, when she was studying at Boston University. Alex Cooper opens up about harassment... In a docuseries, 'Call Her Alex,' which premiered at the Tribeca Festival in New York City on Sunday, June 8, the 30-year-old stated that her former soccer coach used to fixate on her than any other teammate, which was quite confusing for her. '[It] was all based in her wanting to know who I was dating, her making comments about my body, and her always wanting to be alone with me," Cooper said in the docuseries, according to People magazine. The psychotic game Alex, who used to play for BU from 2013 to 2015, revealed that Feldman would allegedly comment on her legs and put her hand on her thigh. Furthermore, the poscaster went on to say that one time the coach asked her if she had been intimate the night before during a private meeting. The professional bond became a 'psychotic game' of if you want to play on the team, you have to tell me about your intimacy, according to Cooper's statement. 'I have to drive you to your night class. Get in the car with me alone,' she recalled what Feldman said. No actions were taken... 'I was attending BU on a full-tuition scholarship. If I didn't follow this woman's rules, I was gone,' Cooper added about not being able to tell about the harassment before. When she told everything to her parents, they contacted a lawyer, who warned her that if she went ahead with the case, the university would likely drag on for years. When Alex's parents wrote a written application about Nancy Feldman's inappropriate conversations, Boston University allegedly did not take any action.
AsiaOne
9 hours ago
- Entertainment
- AsiaOne
Kyra Sedgwick felt emotional shooting break-up scene with real-life husband Kevin Bacon for new movie, Entertainment News
Kyra Sedgwick felt "emotional" while shooting a break-up scene with Kevin Bacon for The Best You Can. The couple — who have been married for 36 years — star in the new rom-com movie, and Kyra admits that one scene proved to be particularly difficult to shoot. Kyra, 59, said at the Tribeca Festival in New York: "There was a moment in the break-up scene where I could not — I was very emotional. I knew [my character] would be emotional, but I had a little crossover of like, 'Oh my god, what if this had happened [in real life]?' "Instead of what happened, which is that we're still together, but 'What if this had happened?' And I got very emotional about it." Kevin recently admitted that he relished the experience of working with his wife. The 66-year-old actor told People: "As soon as you get into a scene, you have a responsibility to your partner to make that scene work, and we've had a partnership for 37 years. "To be able to take some of that time that we've had together and put it up on the screen is just really fun." Meanwhile, Kevin revealed earlier this year that he's tried to shield his children from fame. The Hollywood star — who has son Travis, 35, and daughter Sosie, 33, with Kyra — never took his kids to movie premieres during their younger years and he's always tried to shield them from the pressures of fame. Speaking on Mythical Kitchen's Last Meals, Kevin shared: "We really avoided it. I think we really felt like it would be nice for them to have some… we knew how weird this life was. "When you realise that you will always… that there's always a chance that you're gonna walk out of the house and somebody is going to know who you are or look at you or have some kind of point of you about you from a piece of work that you've done, you start to go, 'Okay, it's great. This is what I always wanted, but it's a weird way to live. Ninety-nine per cent good, but a little weird.'" [[nid:718901]]
Time of India
12 hours ago
- Entertainment
- Time of India
Blake Lively glows in first red carpet appearance after judge tosses Justin Baldoni's lawsuit against her and Ryan Reynolds
Blake Lively didn't hold back from the spotlight on Monday night, making a striking red carpet appearance just hours after a judge dismissed Justin Baldoni's high-profile lawsuit against her. Poised and radiant, the actress stepped out with quiet confidence, her presence speaking volumes in the wake of her significant legal victory. Blake Lively stuns at Chanel's Tribeca Festival dinner Blake attended the Chanel Tribeca Festival Artists Dinner in New York City, where she was joined by her niece, Kate Johnson. The two held hands as they posed for photos, flashing warm smiles and matching energy. The Gossip Girl alum stunned in a white, fitted midi-length dress with delicate straps and what appears to be intricate beadwork or embroidery. Her long, blonde hair was styled in loose waves, complementing her overall elegant and sophisticated look. She completed the ensemble with open-toed, high-heeled sandals. Baldoni's $400M lawsuit against Blake, Ryan Reynolds, and NYT dismissed by judge The same day, Judge Lewis J. Liman tossed out the $400 million lawsuit filed by Lively's It Ends with Us co-star and director, Justin Baldoni, and his company, Wayfarer Studios. The suit accused Blake, her husband Ryan Reynolds, and their publicist of defamation and extortion and also targeted The New York Times for allegedly smearing Baldoni's name. According to People, the judge made it clear in his ruling that the lawsuit didn't hold up under legal scrutiny. 'The Wayfarer Parties have not alleged that Lively is responsible for any statements other than the statements in her CRD complaint, which are privileged,' he wrote, effectively dismissing any claims against Lively. He went on to address the accusations against Ryan Reynolds, publicist Leslie Sloane, and The New York Times, which involved alleged statements about sexual misconduct and a smear campaign. The judge noted that the plaintiffs failed to prove any of them acted with knowledge of falsehood or serious doubt about the truth. 'The Wayfarer Parties have not alleged that Reynolds, Sloane or the Times would have seriously doubted these statements were true based on the information available to them,' Judge Liman explained. He concluded, 'The Wayfarer Parties' additional claims also fail. Accordingly, the Amended Complaint must be dismissed in its entirety.' Blake shares powerful Instagram message after the legal win After the court victory, Blake took to Instagram to speak from the heart. She shared her gratitude and highlighted the importance of standing up for women's safety and voices. 'Like so many others, I've felt the pain of a retaliatory lawsuit, including the manufactured shame that tries to break us,' she wrote. 'While the suit against me was defeated, so many don't have the resources to fight back.' She also encouraged followers to seek out organisations that offer protection and support for women speaking out, ending her message with heartfelt thanks to those who stood by her — whether she knows them personally or not. Blake Lively's allegation against Justin Baldoni Blake Lively officially came forward with her allegations against Justin Baldoni in December 2024, filing a complaint with California's Civil Rights Department. She accused Baldoni of repeatedly crossing boundaries on the set of It Ends With Us, including making inappropriate comments, unwanted touching, and exposing her to explicit material. What made things worse, she claimed, was what followed — a retaliatory smear campaign, allegedly orchestrated by Baldoni and his team at Wayfarer Studios. Just days later, on December 31, the Another Simple Favor actress took things further by filing a federal lawsuit in New York, turning her complaint into a formal legal battle.
